ÂÜÀòÂÒÂ×

Kamin Johnson is a seasoned scientist with extensive experience in toxicology and molecular biology. Currently serving as a Principal Investigator at Corteva, Kamin Johnson leads initiatives in the Predictive Safety Center, focusing on the development of in vitro tools for assessing mammalian toxicity, evaluating the safety of discovery-stage molecules, and mentoring within the Regulatory Science function. Previous roles include toxicologist at The Dow Chemical Company and affiliated scientist at the University of Delaware, in addition to research positions at notable institutions such as Nemours Alfred I. duPont Hospital for Children and The Hamner Institutes for Health Sciences. Kamin Johnson holds a Ph.D. in Molecular Cell Biology from Brown University and a B.S. in Genetics from The University of Georgia.